KGMU to get new diagnostic centre, accommodation block
2
Lucknow: To improve patient care and convenience, King George's Medical University (KGMU) will soon establish a state-of-the-art diagnostic centre & patient relative accommodation (PRA) block to offer round-the-clock access to all essential diagnostic tests under one roof.
The new facility will be located near the existing trauma centre.
The announcement was made on Monday during the launch of several new healthcare services at KGMU by Chief Minister
Yogi Adityanath
.
KGMU vice-chancellor Prof Soniya Nityanand expressed gratitude to the CM for approving this initiative, which is a part of a broader set of 941 health-related projects across the state.
She said that the diagnostic centre and accommodation block would reduce the hassle faced by patients and their attendants, who had to move to various departments for different investigations.
The block will include a 20-bed paediatric trauma wing and a mass casualty wing. It will also strengthen and support the services of existing trauma block, ensuring timely diagnosis and treatment.
Prof Nityanand also outlined the details of the newly constructed multi-storey building at Lari Cardiology Centre, the launch of the Superspecialty Centre for Orthopaedics, and the expansion of the guest house. She spoke about the upcoming foundation stone laying for a 500-bed Trauma-II facility, a new general surgery department building, and an academic block.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
They Were So Beautiful Before; Now Look At Them; Number 10 Will Shock You
Reportingly
Undo
"These new facilities will enhance KGMU's capacity to serve patients not only from the city but also from across UP and neighbouring states. With expanded cardiology and trauma care, along with advanced orthopaedic and surgical units, we are moving closer to our goal of delivering world-class, affordable healthcare under one roof," she said.
Deputy chief minister Brajesh Pathak said that KGMU had earned a world-class reputation over its 120-year journey, thanks to its students and faculty.
"From 1985 to 2023, KGMU received only Rs 1,600 crore, whereas in the last three years alone, this govt provided Rs 1,000 crore under various schemes and planned projects, along with an additional Rs 600 crore for equipment. This shows the resolve of our govt," he said.
He urged the KGMU administration to ensure that no patient is turned away without treatment. "If someone cannot afford treatment, contact me. I will arrange help through various schemes and sources," he added.
Medical education minister Mayankeshwar Sharan Singh said that patients not only from UP but also from neighbouring states and even Nepal come to KGMU.
"People are also being referred here from Gorakhpur AIIMS. Our expectation is that, even if we are not Delhi AIIMS, we should be better than others," he said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
42 minutes ago
- Time of India
What happened to Bruce Willis? The 'Die Hard' actor who reportedly has difficulty in speaking and reading
Bruce Willis , the Hollywood icon who is renowned for 'Die Hard,' has taken a turn for the worse health conditions due to frontotemporal dementia (FTD). The recent reports suggest that the 70-year-old actor has gone non-verbal, in addition to walking and remembering his precious career. About Bruce Willis and his health After noticing the early signs, Willis decided to retire in 2022 after being diagnosed with aphasia, a condition that affects communication. However, in 2023, the family revealed that the condition has gotten serious, and has progressed to frontotemporal dementia, a condition that affects motor skills, speech and behaviour. According to The Express Tribune, the reports from 2023 and 2024 claim that the actor has largely gone non-verbal and is difficult to read. Moreover, the actor has allegedly been facing motor issues, while the family has not confirmed any details yet. In a heartfelt gesture, the '12 Monkeys' actor's family reassured the fans that while the condition seems to be progressive, he remains strong and stable. What is FTD? According to Mayo Clinic, Frontotemporal Dementia is an umbrella term that defines the diseases that affect frontal and temporal lobes of the brain, the areas which are associated with personality, behaviour and language. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like American Investor Warren Buffett Recommends: 5 Books For Turning Your Life Around Blinkist: Warren Buffett's Reading List Undo While the disease can be misdiagnosed as a mental health condition or Alzeimer's disease, FTD occurs at a much younger age, from 40 to 65. The symptoms that affect individuals who have been diagnosed with FTD The symptoms of FTD involves behavioural changes, that includes lack of judgement, increasing inappropriate social behaviour, apathy, decline in personal hygiene and more; speech and language symptoms that include difficulty understanding spoken and written language, no longer understanding meaning of words, trouble in naming things, mistakes in sentence building and more; and movement conditions that includes inappropriate laughing or crying, tremor, muscle weakness, trouble swallowing, and more.
News18
42 minutes ago
- News18
Dr Reddys profit rises marginally to Rs 1,410 cr in Jun qtr
New Delhi, Jul 23 (PTI) Dr Reddy's Laboratories on Wednesday reported a marginal increase in consolidated net profit to Rs 1,410 crore in the June quarter, aided by sustained growth in Europe and India. The Hyderabad-based drug major posted a net profit of Rs 1,392 crore in the year-ago period. Consolidated revenue rose 11 per cent to Rs 8,545 crore in the period under review from Rs 7,673 crore a year earlier. 'We delivered double-digit growth this quarter over the same period last year, reflecting our strength in branded markets and positive momentum in the Nicotine Replacement Therapy portfolio," Dr Reddy's Co-Chairman & MD G V Prasad said. The pricing pressure on Lenalidomide is expected to intensify in the US generics market, he noted. 'We remain focused on strengthening our base business by delivery of our pipeline assets, improving overall productivity and business development," Prasad said. The company noted that growth during the quarter was broad-based, aided by contributions from the acquired consumer healthcare portfolio in nicotine replacement therapy (NRT) and sustained performance in the company's branded markets. In the North American market, its revenue declined by 11 per cent year-on-year to Rs 3,412 crore in the June quarter as compared with Rs 3,846 crore in the year-ago period. The decline was primarily due to increased price erosion in certain key products, including Lenalidomide, it stated. In Europe, the company reported a revenue of Rs 1,274 crore for the first quarter as compared with Rs 526 crore in the year-ago period. The growth in Europe was largely driven by revenues from the acquired NRT portfolio and incremental contributions from new product launches, though partly offset by price erosion, it stated. In India, revenue stood at Rs 1,471 crore against Rs 1,325 crore, a growth of 11 per cent year-on-year. Growth for the quarter was driven by introduction of new products, price increases and commercial execution, Dr Reddy's said. Shares of the company ended 0.58 per cent up at Rs 1,247.55 apiece on the BSE. PTI MSS MSS SHW view comments First Published: July 23, 2025, 18:15 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Time of India
an hour ago
- Time of India
Brain-eating amoeba outbreaks in the US: The first signs you should never ignore
South Carolina's Prisma Health Children's Hospital has reported its first confirmed case of a fatal infection caused by Naegleria fowleri, commonly known as the brain-eating amoeba. The hospital announced on Tuesday that the infected patient has died. Although infections are extremely rare, understanding how they occur and recognizing the early warning signs is important. What is Naegleria fowleri? Commonly referred to as a brain-eating amoeba, Naegleria fowleri is a microscopic, single-celled organism found in warm freshwater environments. Although several species of Naegleria exist, only the fowleri species is known to cause primary amebic meningoencephalitis (PAM), a rare but almost always fatal brain infection. The amoeba poses a risk only when infected water enters the nose. From there, it can travel to the brain and cause PAM. However, drinking water with N. fowleri does not lead to infection. It was first discovered in 1956 and initially identified in Australia. N. fowleri is now known to occur naturally in parts of the U.S., especially in southern states. The organism typically measures between 8 to 15 micrometers and survives by feeding on bacteria. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Why seniors are rushing to get this Internet box – here's why! Techno Mag Learn More Undo Under unfavorable conditions, it transforms into a dormant cyst. In warm, nutrient-rich water, it becomes active and potentially dangerous. Where is it found? This organism thrives in warm, freshwater environments, typically in water temperatures up to 115°F. Thus, it can be found in lakes and ponds during summer, warm, slow-moving rivers, mud puddles, hot springs, poorly maintained swimming pools or spas, untreated well or municipal water, and aquariums. Naegleria fowleri cannot survive in saltwater or in properly chlorinated pools and municipal water systems. Although rare, there have been cases where the amoeba was found in tap water, particularly in systems with inadequate treatment or maintenance. Warning signs and symptoms PAM symptoms usually appear within one to 12 days after exposure. Early signs may mimic viral meningitis and include: severe headache, fever, nausea, vomiting, stiff neck, and loss of appetite. As the infection progresses, more severe neurological symptoms can develop: Confusion or altered mental status Hallucinations Seizures Loss of balance or coordination Coma Drooping eyelids or blurred vision Loss of sense of taste or smell The disease advances quickly. In most cases, it leads to coma and death within five days of the onset of symptoms. Fatalities usually occur within 1 to 18 days. According to the CDC, fewer than 10 cases are reported in the U.S. each year. However, the fatality rate is extremely high — out of 167 cases documented between 1962 and 2024, only four patients survived.
